Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial

David F Kallmes, B. A. Comstock, L. A. Gray, P. J. Heagerty, W. Hollingworth, J. A. Turner, L. Stout, J. G. Jarvik

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Multiple case series of vertebroplasty outcomes have been published, though no large, placebo controlled trial has yet been performed. Our aim was to report baseline characteristics for the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST), a randomized blinded controlled study of vertebroplasty. MATERIALS AND METHODS: We compared baseline demographics, pain scores, and scores on the modified Roland-Morris Disability Scale (RMDS), a back pain-specific metric, between 2 groups. One group included subjects enrolled at the lead INVEST site (n = 27 to date). The second group consisted of eligible patients seen concurrently at the lead INVEST site, who declined enrollment (n = 70). Comparisons were made by using 2-sample t tests. RESULTS: Mean ages were similar between groups, averaging approximately 74 years among study participants and 77 years among nonenrolled eligible patients (P = .17). Approximately 75% of subjects were female in both groups. RMDS scores of enrolled patients at the lead site (18.0 ± 4.2) were not statistically different from those of eligible nonenrolled patients at the lead site (18.6 ± 3.6, P = .49). Pain scores in the enrolled subjects were measured as "average intensity over the prior 24 hours" with mean scores of 7.6 ± 2.1 among enrolled patients at the lead site. Pain scores in eligible nonenrolled patients were measured as "pain at rest," with mean score of 3.4 ± 3.3, and "pain with activity," with mean score of 8.5 ± 2.0. CONCLUSIONS: Patient demographics among subjects enrolled in the INVEST are similar to those in a cohort of eligible nonenrolled patients. Back pain-specific disability was similar between subjects enrolled in the INVEST study and eligible nonenrolled patients at the lead site.

Original languageEnglish (US)
Pages (from-to)1203-1205
Number of pages3
JournalAmerican Journal of Neuroradiology
Volume30
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Vertebroplasty
Safety
Pain
Back Pain
Demography
Lead
Placebos

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging

Cite this

Kallmes, D. F., Comstock, B. A., Gray, L. A., Heagerty, P. J., Hollingworth, W., Turner, J. A., ... Jarvik, J. G. (2009). Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial. American Journal of Neuroradiology, 30(6), 1203-1205. https://doi.org/10.3174/ajnr.A1519

Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial. / Kallmes, David F; Comstock, B. A.; Gray, L. A.; Heagerty, P. J.; Hollingworth, W.; Turner, J. A.; Stout, L.; Jarvik, J. G.

In: American Journal of Neuroradiology, Vol. 30, No. 6, 06.2009, p. 1203-1205.

Research output: Contribution to journalArticle

Kallmes, DF, Comstock, BA, Gray, LA, Heagerty, PJ, Hollingworth, W, Turner, JA, Stout, L & Jarvik, JG 2009, 'Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial', American Journal of Neuroradiology, vol. 30, no. 6, pp. 1203-1205. https://doi.org/10.3174/ajnr.A1519
Kallmes, David F ; Comstock, B. A. ; Gray, L. A. ; Heagerty, P. J. ; Hollingworth, W. ; Turner, J. A. ; Stout, L. ; Jarvik, J. G. / Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial. In: American Journal of Neuroradiology. 2009 ; Vol. 30, No. 6. pp. 1203-1205.
@article{56dc8f65ffa643ed9d102bb740231ce0,
title = "Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial",
abstract = "BACKGROUND AND PURPOSE: Multiple case series of vertebroplasty outcomes have been published, though no large, placebo controlled trial has yet been performed. Our aim was to report baseline characteristics for the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST), a randomized blinded controlled study of vertebroplasty. MATERIALS AND METHODS: We compared baseline demographics, pain scores, and scores on the modified Roland-Morris Disability Scale (RMDS), a back pain-specific metric, between 2 groups. One group included subjects enrolled at the lead INVEST site (n = 27 to date). The second group consisted of eligible patients seen concurrently at the lead INVEST site, who declined enrollment (n = 70). Comparisons were made by using 2-sample t tests. RESULTS: Mean ages were similar between groups, averaging approximately 74 years among study participants and 77 years among nonenrolled eligible patients (P = .17). Approximately 75{\%} of subjects were female in both groups. RMDS scores of enrolled patients at the lead site (18.0 ± 4.2) were not statistically different from those of eligible nonenrolled patients at the lead site (18.6 ± 3.6, P = .49). Pain scores in the enrolled subjects were measured as {"}average intensity over the prior 24 hours{"} with mean scores of 7.6 ± 2.1 among enrolled patients at the lead site. Pain scores in eligible nonenrolled patients were measured as {"}pain at rest,{"} with mean score of 3.4 ± 3.3, and {"}pain with activity,{"} with mean score of 8.5 ± 2.0. CONCLUSIONS: Patient demographics among subjects enrolled in the INVEST are similar to those in a cohort of eligible nonenrolled patients. Back pain-specific disability was similar between subjects enrolled in the INVEST study and eligible nonenrolled patients at the lead site.",
author = "Kallmes, {David F} and Comstock, {B. A.} and Gray, {L. A.} and Heagerty, {P. J.} and W. Hollingworth and Turner, {J. A.} and L. Stout and Jarvik, {J. G.}",
year = "2009",
month = "6",
doi = "10.3174/ajnr.A1519",
language = "English (US)",
volume = "30",
pages = "1203--1205",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "6",

}

TY - JOUR

T1 - Baseline pain and disability in the investigational vertebroplasty efficacy and safety trial

AU - Kallmes, David F

AU - Comstock, B. A.

AU - Gray, L. A.

AU - Heagerty, P. J.

AU - Hollingworth, W.

AU - Turner, J. A.

AU - Stout, L.

AU - Jarvik, J. G.

PY - 2009/6

Y1 - 2009/6

N2 - BACKGROUND AND PURPOSE: Multiple case series of vertebroplasty outcomes have been published, though no large, placebo controlled trial has yet been performed. Our aim was to report baseline characteristics for the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST), a randomized blinded controlled study of vertebroplasty. MATERIALS AND METHODS: We compared baseline demographics, pain scores, and scores on the modified Roland-Morris Disability Scale (RMDS), a back pain-specific metric, between 2 groups. One group included subjects enrolled at the lead INVEST site (n = 27 to date). The second group consisted of eligible patients seen concurrently at the lead INVEST site, who declined enrollment (n = 70). Comparisons were made by using 2-sample t tests. RESULTS: Mean ages were similar between groups, averaging approximately 74 years among study participants and 77 years among nonenrolled eligible patients (P = .17). Approximately 75% of subjects were female in both groups. RMDS scores of enrolled patients at the lead site (18.0 ± 4.2) were not statistically different from those of eligible nonenrolled patients at the lead site (18.6 ± 3.6, P = .49). Pain scores in the enrolled subjects were measured as "average intensity over the prior 24 hours" with mean scores of 7.6 ± 2.1 among enrolled patients at the lead site. Pain scores in eligible nonenrolled patients were measured as "pain at rest," with mean score of 3.4 ± 3.3, and "pain with activity," with mean score of 8.5 ± 2.0. CONCLUSIONS: Patient demographics among subjects enrolled in the INVEST are similar to those in a cohort of eligible nonenrolled patients. Back pain-specific disability was similar between subjects enrolled in the INVEST study and eligible nonenrolled patients at the lead site.

AB - BACKGROUND AND PURPOSE: Multiple case series of vertebroplasty outcomes have been published, though no large, placebo controlled trial has yet been performed. Our aim was to report baseline characteristics for the Investigational Vertebroplasty Efficacy and Safety Trial (INVEST), a randomized blinded controlled study of vertebroplasty. MATERIALS AND METHODS: We compared baseline demographics, pain scores, and scores on the modified Roland-Morris Disability Scale (RMDS), a back pain-specific metric, between 2 groups. One group included subjects enrolled at the lead INVEST site (n = 27 to date). The second group consisted of eligible patients seen concurrently at the lead INVEST site, who declined enrollment (n = 70). Comparisons were made by using 2-sample t tests. RESULTS: Mean ages were similar between groups, averaging approximately 74 years among study participants and 77 years among nonenrolled eligible patients (P = .17). Approximately 75% of subjects were female in both groups. RMDS scores of enrolled patients at the lead site (18.0 ± 4.2) were not statistically different from those of eligible nonenrolled patients at the lead site (18.6 ± 3.6, P = .49). Pain scores in the enrolled subjects were measured as "average intensity over the prior 24 hours" with mean scores of 7.6 ± 2.1 among enrolled patients at the lead site. Pain scores in eligible nonenrolled patients were measured as "pain at rest," with mean score of 3.4 ± 3.3, and "pain with activity," with mean score of 8.5 ± 2.0. CONCLUSIONS: Patient demographics among subjects enrolled in the INVEST are similar to those in a cohort of eligible nonenrolled patients. Back pain-specific disability was similar between subjects enrolled in the INVEST study and eligible nonenrolled patients at the lead site.

UR - http://www.scopus.com/inward/record.url?scp=67449143726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67449143726&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A1519

DO - 10.3174/ajnr.A1519

M3 - Article

C2 - 19246522

AN - SCOPUS:67449143726

VL - 30

SP - 1203

EP - 1205

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 6

ER -